KK
CSTL icon

KLP Kapitalforvaltning’s Castle Biosciences CSTL Stock Holding History

KLP Kapitalforvaltning’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Hold
6,200
– – ﹤0.01% 2006
2026
Q1 		$152K Hold
6,200
– – ﹤0.01% 1923
2025
Q4 		$241K Sell
6,200
-2,700
-30% -$87K ﹤0.01% 1773
2025
Q3 		$203K Buy
8,900
+4,100
+85% +$83.3K ﹤0.01% 1822
2025
Q2 		$98K Hold
4,800
– – ﹤0.01% 2047
2025
Q1 		$96.1K Hold
4,800
– – ﹤0.01% 2041
2024
Q4 		$128K Buy
+4,800
New +$146K ﹤0.01% 2001

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's CSTL Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Castle Biosciences (CSTL) position steady in Q2 2026 at 6,200 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

KLP Kapitalforvaltning first reported a position in CSTL in Q4 2024 and has held it in 7 quarters since. The position peaked at $241K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • KLP Kapitalforvaltning held 6,200 shares of Castle Biosciences worth $148K as of Q2 2026.
  • KLP Kapitalforvaltning left its Castle Biosciences share count unchanged in Q2 2026.
  • Castle Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2006 holding.
  • KLP Kapitalforvaltning first reported a position in Castle Biosciences in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Castle Biosciences position peaked at $241K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.